Currently, the most common drugs used for the treatment of colitis include 5-aminosalicylates, mesalamine, corticosteroids, immunosuppressants and anti-TNF-ɑ monoclonal antibodies, which suppress the intestinal inflammatory burden and improve the disease-related symptoms. This evidence concerns the gene TNF and colitis.